INSIGHTS ON SOLID DOSE MANUFACTURING

  • Zhunan Facility Site VR Tour
    12/23/2025

    Bora’s 36,000-square-meter Zhunan, Taiwan facility delivers flexible, high-quality cGMP oral solid dose manufacturing with access to major markets including North America and the EU.

  • Improving API Solubility Using Hot Melt Extrusion Formulation
    2/27/2025

    Solubility of active pharmaceutical ingredients (APIs) is a challenge in drug development. Discover how hot melt extrusion with polyvinyl alcohol enhances API solubility and stability to offer improved drug delivery.

  • Benefits Of Isolator Technology In Fill-Finish
    12/10/2025

    Isolator technology enhances sterility assurance, reduces contamination risk, improves operator safety, and supports regulatory compliance, making it essential for modern aseptic fill-finish operations.

  • A Brief History Of Aseptic Processing
    3/27/2025

    From Bunsen burners to advanced isolators, aseptic processing has evolved significantly. Delve into the evolution of this crucial manufacturing method, from its early sterilization techniques to today's highly controlled and regulated environments.

  • Solubility And Improved Patient Outcomes
    9/9/2026

    Poor solubility poses major development challenges. Innovative formulation technologies and careful excipient selection can improve bioavailability and product performance.

SOLID DOSE MANUFACTURING SOLUTIONS

  • AIM™ Pro Plus Control System Makes Tablet Production Easy
    The Natoli AIM™ Pro Plus control system is a flexible software and hardware architecture that is standard on Natoli production tablet presses. This industry-leading package can be retrofitted to almost any production tablet press to increase production, improve tablet consistency, and provide an easier-to-manage production environment.

  • Ensure sterile compliance and safety by understanding proper airflow and pressure dynamics in your compounding workflow. Choose the right hardware for your facility.

  • Used Shionogi Qualicaps quali-fill capsule filling machine, serial# 96-F40.

  • When AST came to the table on the design for our new fill-finish isolator, one of the first areas AST engineers wanted to address was the usability and accessibility of the isolator and corresponding operations. With our customers’ point of view in mind, we wanted to address specific points of friction routinely encountered by operators and closely examine whether those friction points were necessary.

    Does an isolator need to be ergonomically unfriendly to clean?

    Should simple mechanisms like isolator doors be challenging to engage? (As much as one can appreciate exercise, no one wants to do “arm day” in cleanroom coveralls).

    Does routine maintenance have to be time-consuming and laborious?

    Many of these factors are accepted as par for the course in aseptic fill-finish manufacturing. Our question was, why?

  • Bringing oral solid dosage pharmaceuticals to market requires expert support. Explore how you can secure supply integrity throughout product lifecycles.